Stem cell-based therapeutic strategies for rotator cuff tendinopathy

Area of Science:

• Orthopedics and Sports Medicine
• Regenerative Medicine
• Biotechnology

Background:

• Rotator cuff tendinopathy is a prevalent musculoskeletal condition with substantial health and economic impacts.
• Stem cell therapy offers potential for tendon healing in advanced rotator cuff tendinopathy.
• Current clinical applications of stem cell therapy are limited despite promising trial results.

Purpose of the Study:

• To review optimal stem cell sources for rotator cuff tendinopathy.
• To establish principles for selecting appropriate stem cell dosages.
• To propose strategies for standardizing stem cell populations and patient selection.

Main Methods:

• Literature review of clinical trials and preclinical studies on stem cell therapy for rotator cuff tendinopathy.
• Analysis of factors influencing stem cell efficacy, including source, dose, and delivery.
• Exploration of methods to address cell heterogeneity and patient stratification.

Main Results:

• Identified key stem cell sources and their characteristics relevant to tendon regeneration.
• Outlined dosage considerations based on current evidence and proposed ranges.
• Highlighted the need for standardized protocols for cell preparation and patient matching.

Conclusions:

• Optimal stem cell source and dosage remain critical for rotator cuff tendinopathy treatment.
• Standardization of cell populations and patient selection are essential for successful clinical translation.
• Further research is needed to overcome current limitations and facilitate widespread adoption.